Skip to content

TMO

Thermo Fisher Scientific Inc.

Shareholders' equity, 2025
$53.4B
YoY, 2025
+7.7%
5-year CAGR
+9.1%
10-year CAGR
+9.6%

Shareholders' equity

Shareholders' equity by fiscal year

PeriodEquityYoY
2025$53.4B+7.7%
2024$49.6B+6.1%
2023$46.7B+6.3%
2022$44.0B+7.8%
2021$40.8B+18.2%
2020$34.5B+16.3%
2019$29.7B+7.6%
2018$27.6B+8.6%
2017$25.4B+18.0%
2016$21.5B+0.9%
2015$21.4B+3.9%
2014$20.5B+21.9%
2013$16.9B+9.0%
2012$15.5B+2.8%
2011$15.0B−2.1%
2010$15.4B−0.5%
2009$15.4B+3.4%
2008$14.9B+3.2%
2007$14.5B—